4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Zydus Lifesciences Limited (ZYDUSLIFE) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Ahmedabad, India with about 29,980 employees. Its market capitalization is roughly ₹1.16 trillion. In the fiscal year ended 2026-03-31, ZYDUSLIFE reported ₹267.2B in revenue and ₹50.4B in net income.
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹267.2B | ₹225.7B | ₹190.2B | ₹168.8B | — |
| Gross Profit | ₹190.6B | ₹159.1B | ₹125.2B | ₹103.2B | — |
| Operating Income (EBIT) | ₹57.9B | ₹59.8B | ₹45.4B | ₹28.5B | — |
| Net Income | ₹50.4B | ₹45.3B | ₹38.6B | ₹19.6B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹78.0B | ₹74.3B | ₹67.8B | ₹64.7B | ₹62.9B | — |
| Gross Profit | ₹55.6B | ₹54.6B | ₹49.4B | ₹46.8B | ₹45.9B | — |
| Operating Income (EBIT) | ₹13.2B | ₹14.0B | ₹12.9B | ₹17.9B | ₹19.3B | — |
| Net Income | ₹9.4B | ₹12.7B | ₹10.4B | ₹14.7B | ₹11.7B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹11.1B) | (₹3.0B) | (₹6.2B) | (₹2.7B) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹524.1B | ₹372.0B | ₹292.8B | ₹257.6B | — |
| Total Liabilities | ₹228.2B | ₹108.4B | ₹71.8B | ₹60.7B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ZYDUSLIFE viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms